Smithfield Trust’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
VPM
VCM
KBG
PMG
Smithfield Trust's OGN Position: Q1 2026 in Review
Smithfield Trust reduced its Organon & Co (OGN) stake by 9.2% in Q1 2026, selling an estimated $670 and leaving 876 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1006.
Smithfield Trust first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $76K in Q2 2021. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.
- Smithfield Trust held 876 shares of Organon & Co worth $4K as of Q1 2026.
- Smithfield Trust sold 89 Organon & Co shares in Q1 2026, an estimated $670.
- Organon & Co made up ﹤0.01% of Smithfield Trust's portfolio in Q1 2026, its #1006 holding.
- Smithfield Trust first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
- Smithfield Trust's Organon & Co position peaked at $76K in Q2 2021.
- 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.
Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.